- 
	Viral Infections
- 
	COVID-19
- 
	Therapy Studies
	- 
		COMIHY
		Hydroxychloroquine for the treatment of mild COVID-19 disease 
- 
		COVARI
		A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI) 
- 
		COVID-19 ACTT-EU/UK
		A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults – Version for European Union/United Kingdom Sites 
- 
		COVID-19 EFC16844
		An adaptive phase 2/3, randomized, double-blind, placebocontrolled study assessing efficacy and safety of sarilumab for hospitalized patients with COVID19 
- 
		COVID-19 Hydroxychloroquine for COVID-19
		Randomized controlled trial of hydroxychloroquine versus placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19 
- 
		COVID-19 XPORT-CoV-1001
		A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe Covid-19 Infection 
- CovidVal01
- COVit
- 
		GI-HOPE
		GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEstoration 
- 
		GS-US-540-5773
		Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) 
- 
		GS-US-540-5774
		A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment 
- 
		RECOVER
		A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease 
- 
		RuxoCoFlaM
		A Phase-II Clinical Trial for First Line Treatment of Stage II/III Covid-19 Patients to Treat Hyperinflammation 
- 
		RUXOCOIL
		A single-arm, open-label, phase II study of ruxolitinib in Covid-19 patients at risk of developing acute respiratory distress syndrome 
- 
		WHO-SOLIDARITY-GERMANY
		An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care - WHO-SOLIDARITY-GERMANY 
 
- 
		COMIHY
		
- 
	Impfstudien
	Nichts anzuzeigen.
- Prophylaxis Studies
- Antibody Studies
- 
	Compassionate Use Programme
	- 
		COVID-19 Remdesivir Compassionate Use
		Remdesivir compassionate use program 
 
- 
		COVID-19 Remdesivir Compassionate Use
		
- 
	Diagnostic Studies
	- 
		Antigen POC Tests COVID-19
		Evaluation of the performance of novel rapid diagnostics for SARS-CoV-2 at point-of-care 
 
- 
		Antigen POC Tests COVID-19
		
- 
	Non-interventional Studies, Biobanking, Registries
	- 
		Aspergillosis in COVID19 on ICU
		Pulmonary Aspergillosis in Critically Ill COVID19 Patients in Intensive Care Unit - a Multinational Explorative Trial 
- CoPa
- Corona und Kognition
- CORSAAR
- COVID-19 Case-Cluster-Study-Heinsbergstudie
- 
		COVID-19 LEOSS Register
		Lean European Open Survey on SARS-CoV-2 
- 
		COVID-19 Mobile Tests für Köln - Community
		COVID-19 Mobile Tests für Köln - Community 
- 
		COVID-19 Mobile Tests für Köln - Uniklinik
		COVID-19 Mobile Tests for Cologne 
- GPN Register für COVID-19
- 
		ISI - Improving Diagnosis of Severe Infections in Immunocompromised Patients
		Improving Diagnosis of Severe Infections in Immunocompromised Patients (ISI) 
- 
		Kidney in COVID-19
		Kidney in Coronavirus Disease 2019 Registry 
- 
		Pa-COVID-19
		Phenotyping platform and logitudinal register for COVID-19 patients at Charité 
- ProCoV
- 
		PROTEGO
		Evaluation of the course of COVID-19 disease and perceptions among those tested positive – a prospective and retrospective survey based study 
- PROVID-CAPSyS
- PROVID-PROGRESS
- Telemed500-Covid-19
 
- 
		Aspergillosis in COVID19 on ICU
		
- 
	Master Protocols
	- 
		COVID-19 Clinical Trials Master Protocol
		A Multi-center, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients 
 
- 
		COVID-19 Clinical Trials Master Protocol
		
- SARS-CoV-2 Best Practice
 - 
		COVARI
		A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI) 
- PROVID-CAPSyS
- PROVID-PROGRESS
- Telemed500-Covid-19
 
- 
	Therapy Studies
	
- MERS-CoV
- Ebola
- Hepatitis
- HIV / AIDS
- Influenza
- Varizella zoster
 
- 
	COVID-19
- Bacterial Infections
- Infections in the immunocompromised host
- Invasive fungal infections
- Gastrointestinal infections
- Parasitic diseases